Future Frontier: mRNA Allergy Vaccines
When you look at the sheer numbers, the Allergy Vaccine Market is entering the "Genomic Era." In 2026, the same mRNA technology used for COVID-19 is being adapted for allergies. Instead of injecting the allergen itself, these vaccines provide instructions to the body to produce "Regulatory T-cells" that naturally suppress the allergic reaction. The US Allergy Vaccine Market is the global...
0 Kommentare 0 Geteilt 56 Ansichten 0 Bewertungen
Gesponsert